主页 > 医学动态 >
【drug-news】借助计算机模型科学家有望缩短新型
ScienceDaily (Feb. 12, 2011) — Eliminating tens of thousands of manual lab experiments, two University of Houston (UH) professors are working toward a method to cut the development time of new antibiotics. While current practices typically last for more than a decade, a computerized modeling system being developed at UH will speed up this process.
Vincent Tam, associate professor of clinical sciences, and Michael Nikolaou, professor of chemical and biomolecular engineering, are focusing on dosing regimens to reveal which ones are most likely to be effective in combating infection and which are not worth pursuing. It is hoped that pharmaceutical companies can then focus their tests on the most promising regimens.
Their findings recently appeared in the Public Library of Science's PLoS Computational Biology. This article chronicles the results of a three-year endeavor that was initially funded by a $400,000 grant from the National Science Foundation.
"With microbial resistance to drugs increasing, there is a need to develop new antimicrobial agents rapidly," Tam said. "Our work proposes a new computational method that will provide quantitative insight to the interaction between certain antibiotics and pathogens. Through pharmacodynamic modeling, which studies the effects of drugs on organisms, our aim is to both help develop new antibiotics and optimize existing medications to curb the prevalence of drug-resistant bacteria."
The traditional approach to drug development involves a great deal of trial-and-error testing, such as empirically selecting a handful of dosing regimens for clinical investigations among hundreds of possibilities -- only time will tell its effectiveness. Tam and Nikolaou, however, are employing computer modeling and simulation to project how bacteria would respond to different exposures of a drug, focusing on how much medicine a patient should take, how often it should be taken and for how many days. Subsequent investigations in clinical studies can then target those dosing methods that have the highest probabilities of success.
Tam, an expert on experimental therapeutics, and Nikolaou, with a background in computer-aided systems engineering, forged their collaboration through a seed grant from UH before they attracted external funding. Their modeling approach relies on fundamental laws of nature, which are exploited to generate future projections from scant experimental inputs through computer simulation. This has been demonstrated to be better than simple human eyeballing.
"Our approach gives us the ability to take extra variables into consideration in an attempt to develop a more robust computational tool that covers a wider spectrum of relevant scenarios in new drug development," Nikolaou said. "Some pharmaceutical companies are following our developments closely, and we are in the process of refining a model prototype in the form of a computer program to ultimately be used in a clinical setting."
http://www.sciencedaily.com/releases/2011/02/110211095543.htm 开发新药品文件类型:DOC/Microsoft Word- 文字版总之,中药新药的研究开发必须坚持以中医药理论和经验为基础,采用现代科学技术的方法,... 涉及大量生物学和化学数据的产生与使用,必需有良好的信息管理系统,借助计算机信息技术,...202.116.88.74/...jm42eqra_.doc-2010-12-28-开发新药品" 染色体 | 生命奥秘有助于研制针对该病的新型药物.相关结果发表在《公共科学图书馆·医学》(PLoS ... http://www.sciencedaily.com/releases/2010/05/100514094834.htm 科学家发现凝集蛋白执行...www.lifeomics.com/...d=2&s=染色体-2010-07-28-快照-生命奥秘" 上海现代制药股份有限公司首次公开发行3300万股人民币普通股招...为了增加药品生产的附加值,充分发挥本公司在新型制剂和手性药物的研究开发、生产工艺... 对策 鉴于医药产品研发具有投入大、周期长、失败率高的特点,故本公司目前尚不计划自...stock.jrj.com.cn/...00rp48.htm-2002-11-22-快照-药股份有限公司首次公开发行3300万股人民币普通股招..."[标签:content2]
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-02-13 23:38
医学,生命科学网